In one afternoon, attendees will gain practical perspective on how rare disease and rare oncology companies can commercialize more efficiently while staying focused on what matters most: reaching patients faster.
In one afternoon, attendees will gain practical perspective on how rare disease and rare oncology companies can commercialize more efficiently while staying focused on what matters most: reaching patients faster.
